Clinical Trials
- Headaches
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2)
- Ages6 years - 17 years
- GenderBoth
- Brain and Other Nervous System Cancers, Leukemia, Lymphoma
A Phase 1, Dose Escalation, and Cohort Expansion Study Evaluating NX-5948, a Bruton's Tyrosine Kinase (BTK) Degrader, in Adults With Relapsed/Refractory B-cell Malignancies
- Ages18 years and older
- GenderBoth
- Brain and Other Nervous System Cancers
A Phase 2, Multicenter, Clinical Study to Evaluate the Efficacy and Safety of Safusidenib Erbumine in Patients With Isocitrate Dehydrogenase 1 (IDH1) Mutant Glioma
- Brain and Other Nervous System Cancers
A Phase 3, Multi-regional, Open-label, Randomized Study of Tirabrutinib vs Rituximab and Temozolomide in Participants With Relapsed/Refractory Primary Central Nervous System Lymphoma
- Brain and Other Nervous System Cancers
A Phase I Trial Combining Triapine With Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- Lymphoma
A Randomized Phase 3 Trial of Continuous vs. Intermittent Maintenance Therapy With Zanubrutinib as Upfront Treatment in Older Patients With Mantle Cell Lymphoma
- Children's Health, Headaches
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1)
- Ages6 years - 17 years
- GenderBoth
- Brain, Spinal Cord & Nervous System
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- Ages18 years and older
- GenderBoth
- Alzheimer's
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease
- Ages50 years - 85 years
- GenderBoth
- Alzheimer's
Alzheimer’s Disease Neuroimaging Initiative 4 (ADNI 4)
- Ages55 years - 90 years
- GenderBoth